Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Simulations Plus price target raised to $60 from $55 at Craig-Hallum » 08:28
07/07/22
07/07
08:28
07/07/22
08:28
SLP

Simulations Plus

$51.20 /

+0.14 (+0.27%)

Craig-Hallum analyst Matt…

Craig-Hallum analyst Matt Hewitt raised the firm's price target on Simulations Plus to $60 from $55 and keeps a Buy rating on the shares. The analyst notes Simulations Plus posted "solid" Q3 results on Wednesday with both the software and services segments beating expectations.

ShowHide Related Items >><<
SLP Simulations Plus
$51.20 /

+0.14 (+0.27%)

SLP Simulations Plus
$51.20 /

+0.14 (+0.27%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$51.20 /

+0.14 (+0.27%)

Earnings
Simulations Plus backs FY22 revenue view $52M-$53M, consensus $52.9M » 16:08
07/06/22
07/06
16:08
07/06/22
16:08
SLP

Simulations Plus

$51.50 /

+0.435 (+0.85%)

"Now that we've…

"Now that we've completed our third quarter and have one quarter remaining in the fiscal year, we are reiterating our full-year revenue guidance at $52-53 million, and tightening the growth rate to 12-15%. Our fourth quarter has historically been impacted by seasonality related to our industry in the summer months and we expect this year to be no different. For services, there tends to be slower engagement on projects during the summer months. For software, growth tends to be skewed towards the first half of our fiscal year, which coincides with new calendar year budgets for many of our customers. Based on the successful performance of our software business through the third quarter, we expect software revenue to exceed 60% of total revenue for the fiscal year," concluded O'Connor.

ShowHide Related Items >><<
SLP Simulations Plus
$51.50 /

+0.435 (+0.85%)

SLP Simulations Plus
$51.50 /

+0.435 (+0.85%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$51.50 /

+0.435 (+0.85%)

Earnings
Simulations Plus reports Q3 EPS 20c, consensus 17c » 16:08
07/06/22
07/06
16:08
07/06/22
16:08
SLP

Simulations Plus

$51.75 /

+0.69 (+1.35%)

Reports Q3 revenue $15M,…

Reports Q3 revenue $15M, consensus $14.33M. "While the growth trend in our software business continued during the third quarter, our services business showed a strong recovery with 19% growth," said Shawn O'Connor, chief executive officer of Simulations Plus. "The services backlog we built over the past few quarters set up this recovery, driven by PBPK and PKPD projects. PBPK was especially strong as we saw deeper penetration of modeling resulting from expanded use cases and perceived value. Looking at our software business, our efforts to expand our addressable market continued to pay off as we saw increased upsells, continued expansion in Asia, and deeper penetration of modeling and simulation with smaller biotech firms."

ShowHide Related Items >><<
SLP Simulations Plus
$51.75 /

+0.69 (+1.35%)

SLP Simulations Plus
$51.75 /

+0.69 (+1.35%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$51.75 /

+0.69 (+1.35%)

Over a quarter ago
Hot Stocks
Simulations Plus announces FDA renewal of DILIsym software platform licenses » 08:59
05/05/22
05/05
08:59
05/05/22
08:59
SLP

Simulations Plus

$47.66 /

+1.26 (+2.72%)

Simulations Plus…

Simulations Plus announced that the FDA has renewed its licenses to the DILIsym software platform, the DILIsym Services division's quantitative systems toxicology, or QST, software for predicting and investigating drug-induced liver injury, or DILI. The one-year renewal provides continued DILIsym software access to FDA employees across all FDA divisions at their discretion through an unlimited licensing package.

ShowHide Related Items >><<
SLP Simulations Plus
$47.66 /

+1.26 (+2.72%)

SLP Simulations Plus
$47.66 /

+1.26 (+2.72%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$47.66 /

+1.26 (+2.72%)

SLP Simulations Plus
$47.66 /

+1.26 (+2.72%)

Hot Stocks
Simulations Plus enters new collaboration to advance DDDPlus software » 08:40
04/21/22
04/21
08:40
04/21/22
08:40
SLP

Simulations Plus

$51.51 /

+0.97 (+1.92%)

Simulations Plus…

Simulations Plus announced a new funded collaboration with a large pharmaceutical company to expand and validate the mechanistic in vitro dissolution models for intravitreal injectable formulations within the DDDPlus software. James Mullin, Senior Principal Scientist and lead programmer on DDDPlus, said: "The DDDPlus software is being utilized by numerous companies and regulatory agencies around the globe to support oral drug product development. Recent enhancements to the tool have focused on improvements to the in vitro analysis of precipitation kinetics and functionality to help establish drug product specification limits. Through this new collaboration, we will expand into the injectable product space and apply our novel approaches to capture dissolution kinetics within in vitro systems designed by our industry partner. We look forward to the fruitful interactions." "Our team of scientists and programmers have designed unique workflows between DDDPlus and GastroPlus to advance innovative in vitro-in vivo extrapolation methods for dissolution and precipitation modeling," added Haiying Zhou, Director of Simulation Technologies. "Turning our attention to injectable products, and the special in vitro systems used to measure formulation performance, opens new market opportunities for our IVIVE workflows. Like other collaborations, Simulations Plus will own all improvements made to our software programs, and we look forward to sharing these exciting developments with all users to advance model-informed drug development."

ShowHide Related Items >><<
SLP Simulations Plus
$51.51 /

+0.97 (+1.92%)

SLP Simulations Plus
$51.51 /

+0.97 (+1.92%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$51.51 /

+0.97 (+1.92%)

SLP Simulations Plus
$51.51 /

+0.97 (+1.92%)

Earnings
Simulations Plus reports Q2 EPS 21c, consensus 14c » 16:09
04/06/22
04/06
16:09
04/06/22
16:09
SLP

Simulations Plus

$48.01 /

+0.24 (+0.50%)

Reports Q2 revenue…

Reports Q2 revenue $14.8M, consensus $13.9M. "We generated solid revenue growth, improved margins and strong EPS growth during the second quarter, demonstrating the health of our business and the operating leverage in our model," said Shawn O'Connor, CEO. "Our software business continued its rapid expansion and our services business generated strong bookings and backlog growth with a large pipeline of opportunities. We delivered double-digit revenue increases across our three major software platforms as a result of our increased upsell efforts and the addition of 18 new customers. MonolixSuite(R) revenue was especially strong, with 43% growth, and is now our second-highest selling software product. The 25% growth in our software business offset the 5% decline in our services business this quarter and software revenue is now contributing over 60% of our revenue. The results represent an encouraging first half of the fiscal year and demonstrate that we are on-pace to achieve our full-year goals."

ShowHide Related Items >><<
SLP Simulations Plus
$48.01 /

+0.24 (+0.50%)

SLP Simulations Plus
$48.01 /

+0.24 (+0.50%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$48.01 /

+0.24 (+0.50%)

SLP Simulations Plus
$48.01 /

+0.24 (+0.50%)

Conference/Events
Simulations Plus management to meet virtually with Craig-Hallum » 04:55
02/08/22
02/08
04:55
02/08/22
04:55
SLP

Simulations Plus

$41.20 /

+0.81 (+2.01%)

Virtual Meeting to be…

Virtual Meeting to be held on February 8 hosted by Craig-Hallum.

ShowHide Related Items >><<
SLP Simulations Plus
$41.20 /

+0.81 (+2.01%)

SLP Simulations Plus
$41.20 /

+0.81 (+2.01%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$41.20 /

+0.81 (+2.01%)

SLP Simulations Plus
$41.20 /

+0.81 (+2.01%)

Conference/Events
Simulations Plus management to meet virtually with Craig-Hallum » 10:59
01/31/22
01/31
10:59
01/31/22
10:59
SLP

Simulations Plus

$41.65 /

+0.73 (+1.78%)

Virtual Meeting to be…

Virtual Meeting to be held on February 8 hosted by Craig-Hallum.

ShowHide Related Items >><<
SLP Simulations Plus
$41.65 /

+0.73 (+1.78%)

SLP Simulations Plus
$41.65 /

+0.73 (+1.78%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$41.65 /

+0.73 (+1.78%)

SLP Simulations Plus
$41.65 /

+0.73 (+1.78%)

Earnings
Simulations Plus reports Q1 EPS 15c, consensus 9c » 16:07
01/06/22
01/06
16:07
01/06/22
16:07
SLP

Simulations Plus

$45.95 /

-1.8 (-3.77%)

Reports Q1 revenue…

Reports Q1 revenue $12.4M, consensus $11.3M. Shawn O'Connor, CEO, said, "Our software business continued to deliver higher revenue and margins in the first quarter, supplemented by improving momentum in our services business, which returned the company to overall double-digit revenue growth. The reinvigorated growth enabled a 22% improvement in net income, demonstrating both the benefit of a higher software versus services revenue mix and the inherent leverage in our operating model."

ShowHide Related Items >><<
SLP Simulations Plus
$45.95 /

-1.8 (-3.77%)

SLP Simulations Plus
$45.95 /

-1.8 (-3.77%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$45.95 /

-1.8 (-3.77%)

SLP Simulations Plus
$45.95 /

-1.8 (-3.77%)

SLP Simulations Plus
$45.95 /

-1.8 (-3.77%)

Options
Simulations Plus options imply 7.2% move in share price post-earnings » 14:04
01/06/22
01/06
14:04
01/06/22
14:04
SLP

Simulations Plus

$46.91 /

-0.84 (-1.76%)

Pre-earnings options…

Pre-earnings options volume in Simulations Plus is 8.4x normal with puts leading calls 7:5. Implied volatility suggests the market is anticipating a move near 7.2%, or $3.36, after results are released. Median move over the past eight quarters is 6.8%.

ShowHide Related Items >><<
SLP Simulations Plus
$46.91 /

-0.84 (-1.76%)

SLP Simulations Plus
$46.91 /

-0.84 (-1.76%)

01/03/22 Sidoti
Simulations Plus reinstated with a Neutral at Sidoti
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Craig-Hallum
Simulations Plus upgraded to Buy from Hold at Craig-Hallum
07/13/21 Craig-Hallum
Simulations Plus price target lowered to $65 from $74 at Craig-Hallum
SLP Simulations Plus
$46.91 /

-0.84 (-1.76%)

SLP Simulations Plus
$46.91 /

-0.84 (-1.76%)

SLP Simulations Plus
$46.91 /

-0.84 (-1.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.